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SUMMARY
The production of anti-snake venom from large mammal’s blood has been found to be low-yielding and arduous, consequently, 
antivenom immunoglobulins for treatment are achieved regularly as polyvalent serum. We have standardized an undemanding technique 
for making purified immunoglobulin IgY antivenom consisting of polyclonal antibodies against coral snake venom in the egg yolk 
of immunized hens. We have adapted a reported process of antibody purification from egg yolks, and achieved 90% antibody purity. 
The customized technique consisted of the removal of lipids from distilled water-diluted egg yolks by a freeze–thaw sequence. The 
specific immunoglobulins were present in the egg yolk for up to 180 days postimmunization. Therefore, by means of small venom 
quantities, a significant amount of immunoglobulins were found in an adequately purified state (The obtained material contained about 
90% pure IgY). The antigen binding of the immunoglobulins was detected by a double immunodiffusion test. Titers of antibodies in 
the yolk were estimated with a serum protection assay (Median effective dose = ED50) (ED50= 477 mg/kg). Given that breeding hens 
is economically feasible, egg gathering is noninvasive and the purification of IgY antibodies is quick and easy, chicken immunization 
is an excellent alternative for the production of polyclonal antibodies. To the best of our knowledge, this is the first coral snake anti-
venom prepared in birds.
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INTRODUCTION
Snake envenomation produces tissue effects such as local swelling 
and necrosis, neurotoxicity and hemostatic disorders. Considerable 
advancement has been made in understanding the pathophysiology of 
ophidic accidents, motivating transformations in treatment procedures. 
Latest advances, including the production of new antivenoms using new 
processes1-4,19, have encouraged developing coral snake antivenoms with 
attractive protocols.
Nearly two hundred species from the Elapidae family are dispersed 
across the Southeastern and Southwestern United States, as well as all of 
Mexico, Central America and South America, and are also established in 
the African, Asian and Oceanic continents3. On the American continent, 
more than 120 species and subspecies have been described, separated 
into three genera: Leptomicrurus with three species, Micruroides, with 
one, and Micrurus, with approximately 70 species21,22.
The production of safe, efficient and reasonably priced antivenoms 
is a priority. Alternative progress in the therapeutics of coral snake 
bite victims in Venezuela requires an answer to the production of new 
animal models, logistical, financial, marketing, delivery and storage 
difficulties related to the supply of antivenom. Furthermore, the norms 
and regulations for physicians to improve antivenom use must also be 
addressed. Even though coral snake envenomations could be handled 
using medications that act on presynaptic and postsynaptic receptors, 
since some patients may only survive under intensive therapy treatment 
such as respiratory support23, specific treatment with antivenoms 
continues to be the elected method for treating these incidents, which can 
efficiently deactivate all systemic activities of the venom. Nevertheless, 
there are some collateral effects of antivenom such as anaphylaxis and 
serum sickness5. The majority of these alterations seem to be caused by 
the action of high concentrated proteins, which are not immunoglobulins, 
but contaminating polyvalent antivenoms. However, the benefits of 
antivenom treatment may be more important than its risks.
The specific therapeutics for coral snake envenomations is the use 
of heterologous antivenom, and to date, this type of antivenom is not 
available in Venezuela. In light of the information that coral snake venom 
can reveal a multiplicity of composition and toxic activities, we have 
included the most important venom species occurring in Venezuela and 
United States in the immunization protocol. At this time, we present a 
study on the production of a specific coral snake (Micrurus) antivenom 
and its purification of immunoglobulins from the egg yolk of immunized 
hens, with the purpose of providing a more efficient antivenom for 
therapeutic treatments.
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MATERIALS AND METHODS
Ethical statement: All the experimental events concerning the 
use of live animals were carried out by specialized staff. The relevant 
regulations of Venezuela as well as institutional guidelines, according 
to protocols approved by the Institute of Anatomy of the Universidad 
Central de Venezuela, and the norms obtained from the guidelines for 
the care and use of laboratory animals13 were followed.
Coral snakes (Micrurus) venom: Venom from a collection (twenty 
specimens) of different Micrurus species from Venezuela and the United 
States were used in the immunization protocol. The venom of Venezuelan 
coral snakes consisted of (Micrurus isozonus (Calabozo, Guárico State), 
Micrurus isozonus (Caracas, D.C), Micrurus isozonus (La Boyera, 
Miranda State), and Micrurus isozonus (Maracay, Aragua State) which 
were supplied by the Serpentarium of the Tropical Medicine Institute of 
the Universidad Central de Venezuela, Caracas, Venezuela. The venom 
from the U.S. consisted of Micrurus fulvius fulvius (Eastern, USA), 
and Micrurus tener tener (Western, USA), purchased from the National 
Natural Toxins Research Center, Texas A&M University-Kingsville, 
Kingsville, Texas, USA.
Fifteen days prior to venom extraction, the coral snakes were fed and 
made to fast to guarantee enough venom in their glands. The venom was 
collected through a 50-mL plastic centrifuge tube transversely cut and 
covered on the top with Parafilm® (Millipore Corp, USA). The snake 
was forced to bite the Parafilm. Venom was collected by glass capillaries 
through the excretory conduit in the base of the fangs, centrifuged, and 
supernatants were placed in Eppendorf® (Eppendorf Int, USA) tubes and 
stored at -30 °C until use. Stock solutions were prepared in phosphate-
buffered saline (PBS) (10 Mm sodium phosphate containing 150 Mm 
NaCl, Ph 7.2) at 1.0 mg/mL.
Mice: Female mice (INH strain) weighing 18-20 g were obtained 
from the Instituto Nacional de Higiene “Rafael Rangel”, Caracas, 
Venezuela. The colony of mice was kept in plastic boxes (Tecniplast, 
Italy) at six mice per cage, in a room maintained at 23 °C on a 12/12-hr 
light/dark cycle.
Hens: Six egg-laying, red hens (Gallus domesticus) of Rhode 
Island strain, approximately 16 weeks old, obtained from a poultry 
farm from Lagunita town, Miranda State, Venezuela, were located in 
individual henhouses (Centenosuplidores C.A, Venezuela)(one hen per 
henhouse) prior to the commencement of the production of eggs. Hens 
were maintained on 12/12-hr light/dark cycle at 23 °C with food and 
water ad libitum.
Determination of protein concentration: Protein determination 
was established by the method of LOWRY et al. 15.
Micrurus’ venom lethality: Lethality of crude venom was 
determined by intravenous injections into mice and the LD50 value 
calculated according to the Spearman-Karber method31. The venom was 
diluted in a phosphate-buffered saline solution (PBS). The endpoint of 
lethality of the mice was determined after 48h. All solutions during the 
experiments were stored at 4 ºC and warmed to 37 ºC prior to being 
injected into mice. The lethal toxicity was determined in five groups 
containing five mice. A total of 0.2 mL of venom (dosages from 0.05 to 
0.8 mg/kg) was injected into the tail vein of 18-20 g female BALB/c mice. 
A comparable volume of PBS was injected as a negative control group.
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE) of coral snake’s crude venom: Pools of different coral 
snakes’ crude venom under non-reduced conditions were electrophoresed 
using a MINIPROTEAN II (BioRad, USA) chamber. SDS-PAGE was 
performed according to the Laemmli method (1970)14 using 15% gels. 
Wide range molecular weight markers (Bio-Rad) were run in parallel 
and gels were stained with Comassie blue (National Diagnostic, USA).
Immunization: A pool was made with concentrations of venom, 
corresponding to the LD50 median. A sub-lethal dose was used for 
immunizations. Four-month-old egg-laying hens, weighing ~1 kg were 
maintained pathogen-free and immunized with the pool of coral snakes’ 
venom. Venom (0.24 mg/kg in 0.1 mL) was taken into an Eppendorf tube 
and then mixed with an equal volume of Freund’s complete adjuvant, 
whereas the second doses consisted of venom emulsified with Freund’s 
incomplete adjuvant (GIBCO, USA). The third venom doses were mixed 
with a saline solution. All doses were administered subcutaneously, via 
the deltoid region in four different places, alternating right and left every 
two weeks for eight weeks. One week after the last dose, the hens’ blood 
was obtained for the detection of immunoglobulins that could recognize 
and precipitate the coral snake venom.
Isolation of immunoglobulin: The modified method of SVENDSON 
et al. (1995)30 using the freeze and thaw principle to remove lipids was used. 
For a brief period, the egg yolk was diluted 10 times with distilled water, 
and the diluted egg yolk was frozen at -80 ºC overnight, and permitted to 
thaw at an increased temperature rate of ~ 2 ºC (six min) by maintaining 
it at 2-4 ºC. The egg yolk was then centrifuged at 18,000 g for 1h at 4 ºC 
and the supernatant gathered was cleared by filtration on Whatman (Nº. 
1) filter paper (Whatman, USA). To precipitate the immunoglobulins, the 
filtered supernatant was then precipitated by 40% ammonium sulfate at 4 
°C. Afterwards, the pellet was re-suspended in 0.01M Tris-HCl (pH 8.0) 
to a volume equal to half of the supernatant. Following centrifugation for 
15 min at 13 000 g, the pellet was washed twice with 40% ammonium 
sulfate (ReAgent, UK). The solution was dialyzed carefully (three buffer 
changes, at least 150 times volume) against 10 mM phosphate buffer, pH 
7.0, for 24 to 48h in a dialyzing tube with molecular cut off weight of 14 
KDa to remove the ammonium sulfate5,19.
Antibody activity and purity were determined using a SDS-PAGE14, 
double gel diffusion test18 and a serum protection test (ED50), respectively.
Gel diffusion assay using specific IgY against coral snake venom: 
To show the specific IgY immunoglobulin activity, a 1% agarose (Sigma-
Aldrich Co. USA) double gel diffusion test was used18. The immunizing 
pool of coral snake crude venom at 10 mg/mL was placed in the central 
well, while different coral snake venoms and PBS were placed in the 
outer wells and incubated at 37 °C.
Serum protection test (Median effective dose = ED50): For antivenom 
effectiveness, five groups of eight mice were challenged with a mixture of 
varying concentrations of IgY antivenom containing three LD50 of venom. 
The antivenom/venom mixture was prepared at 0 °C and incubated for 
30 min at 37 °C prior to injection. Each mouse was injected with 0.2 mL 
of venom/antivenom mixture into the tail vein. The mice were observed 
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for 48 h and the survival percentage and ED50 were calculated according 
to Spearman and Karber31. Saline controls and antivenom controls were 
used. Neutralizing capability was expressed as the 50% effective dose 
(the amount of antivenom that protects 50% of the population) (Table 2).
Specificity of coral snake antivenom (IgY) to various snake venom 
via Western blot: To explore the specificity of the immunoglobulins 
against coral snake venom, the antibodies were also assayed with Crotalus 
and Bothrops venom. A total of nine venom (22 µg/each) consisting of 
M. isozonus, M. surinamensis, M. f. fulvius, M. t. tener, Naja kaouthia, 
Naja pallida, Bothrops colombiensis, Crotalus durissus cumanensis 
and C. vegrandis were electrophoresed on a 10-20% Tricine SDS gel 
using a XCell SureLock™ system at 150V (Bio-Rad PowerPac Basic) 
for one hour. The proteins were transferred onto a 0.2 µm nitrocellulose 
membrane (Millipore) using a Trans Blot SD system (BioRad) at 100 
mA for one hour. The primary antibody (chicken anti-coral snake venom 
IgY) was diluted to 1/200, the secondary antibody (rabbit anti-chicken 
IgY-alkaline phosphatase) (Sigma-Aldrich Co. USA) was diluted to 
1/50,000. SIGMA FAST™ BCIP/NBT tablets were used to visualize the 
bands on the blot and SimplyBlue (Life Technologies, USA) was used to 
visualize the bands on the gel. SeeBluePlus2 (Life Technologies, USA) 
markers were used as standards.
Antivenom: The antivenom passed the standard tests for neutralizing 
potency, miocrobiological purity, lack of pyrogenicity, appropriate protein 
concentration, lack of abnormal toxicity, sterility, and pH (6.9)11.
RESULTS
Lethality assay: The LD50 calculated as a median from the mixture 
of coral snake venom used for immunization was 0.58 mg/kg. The LD50 
values were different among Micrurus venoms tested, with LD50 of 0.32 
mg/kg (Micrurus fulvius), 0.5 mg/kg (Micrurus isozonus) and 0.78 mg/
kg (Micrurus tener) (Table 1).
Immunization: The LD50s for the venoms were carried out according 
to the SÁNCHEZ et al.23 method. A sub-lethal dose of the pool of venoms 
made with concentrations corresponding to the LD50 median of 0.3 mg/
kg, was used to immunize the hens (Table 1).
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE) of coral snake crude venom: The SDS-PAGE (15%) 
protein profiles of Micrurus isozonus venoms were analyzed. The 
individual venom differed in composition, quantity and intensity of bands 
(Fig. 1). The M. isozonus venom from Calabozo contained more protein 
bands above 31.kDa (Fig. 1; lane 2) than all other M. isozonus venom. 
The M. isozonus venom from Caracas and Maracay both contained a 
similar protein band between 66.2 and 97.4 kDa (Fig. 1; lanes 3 and 5, 
respectively). The sample from La Boyera (Fig. 1; lane 4) contained all 
protein bands below 21.5 kDa.
Isolation of immunoglobulin: This method30 involved a gently 
synchronized -70 ºC freeze and 4 ºC thaw cycle, consequently giving 
a clear egg yolk solution. The total protein concentration in one egg 
yolk was around 1.3 ± 0.5 g. In this method, a larger component of the 
additional proteins was excluded through lipid elimination of egg yolk 
by the freeze and thaw cycle. IgY was reduced with β-Mercaptoethanol 
(Sigma-Aldrich Co. USA) showing a heavy chain fragment of 68 kDa 
and light chain of 27 kDa (Fig. 3). The material, after precipitation, 
contained about 90% pure IgY.
Gel diffusion assay using specific IgY against coral snake venom: 
The existence of antivenom IgY in egg yolk was tested by Ouchterlony’s 
immunodiffusion assay18 using crude venom as the antigen (Fig. 2). 
The protein concentration in the wells (1-12) was 1 mg/ mL, and 20 µL 
was added to each well. Antivenom added to the middle well was 
20 µL, containing a concentration of 1 mg/mL Lowry’s protein. Several 
precipitin lines at each location pointed out the polyvalent character of 
the antibodies. The antibody titer augmented after the booster dose, and 
antibodies were present 180 days after the first injection.
Table 1
LD50s of Venezuelan and United States coral snake venoms. Lethality of crude 
venom was determined by intravenous injections into mice and the LD50 value 
calculated according to Spearman-Karber method31
Species Pool LD50a ± SD
M. isozonus La Boyera, Miranda State (Venezuela) 0.5 ± 0.012
M. isozonus Caracas, Capital District (Venezuela) 0.5 ± 0.012
M. isozonus Calabozo, Guárico State (Venezuela) 0.8 ± 0.016
M. isozonus Maracay, Aragua State (Venezuela) 0.6 ± 0.02
M. tener tener Kingsville, Texas State (United States) 0.78 ± 0.14
M. fulvius Tampa, Florida State (United States) 0.32 ± 0.12
a The LD50 is the concentration of venom required to kill 50% of a mouse 
population after 48 h. Results are expressed in mg venom/kg body weight. Mean 
LD50 = 0.58(mg/kg).
Fig. 1 - SDS-polyacrylamide gel electrophoresis (15%) of individual M. isozonus venoms 
from Venezuela. A total of 20 µg of venom sample was applied to the gel. Lanes: 1) Markers; 
2) M. isozonus (Calabozo); 3) M. isozonus (Caracas); 4) M. isozonus (La Boyera); 5) M. 
isozonus (Maracay). The gel was stained with Comassie blue. 
AGUILAR, I.; SÁNCHEZ, E.E.; GIRÓN, M.E.; ESTRELLA, A.; GUERRERO, B. & RODRIGUEZ-ACOSTA, F.A. - Coral snake antivenom produced in chickens (Gallus domesticus). Rev. 
Inst. Med. Trop. Sao Paulo, 56(1): 61-6, 2014.
64
Serum protection test (Median effective dose = ED50): Coral 
snake antivenom (IgY) was able to effectively neutralize the pool of all 
Micrurus isozonus coral snake venom used in the immunization with a 
mean ED50 of 477.8 mg/kg (Table 2).
Specificity of coral snake antivenom (IgY) to various snake venom 
via Western blot: The coral snake antivenom was able to recognize, to 
some degree, all the coral snake venoms used in this study in addition to 
two cobra snake venoms and three Venezuelan pit vipers. The antivenom 
was most specific to M. f. fulvius followed by M. isozonus, M. t. tener and 
M. surinamensis. The two Naja spp. had similar reactions to each other, 
and the two Crotalus spp. also showed similarities. Bothrops colombiensis 
venom had a different reactivity pattern than the other Venezuelan venom. 
Micrurus surinamensis venom had the least reaction with the antivenom 
compared to all the venom tested. No protein bands below 12 kDa were 
detected for any venom.
DISCUSSION
Despite the significant pressure due to death and grave consequences 
resulting from accidents with coral snakes, the research and investment 
of funds for the production of antivenoms is considered insufficient. On 
the other hand, biochemical studies relating to Micrurus venoms are 
limited, due to the complexity of accurately identifying the species, the 
difficulties in maintaining them in captivity, and the difficulty in obtaining 
a desirable amount of venom; in addition, venom varies between intra and 
interspecies in composition, associated with their age, gender, geographic 
distribution, and diet4,10.
In this study, the competence of hens to make antibodies against 
small quantities of antigens was studied. In some conditions, there 
may be problems with getting adequate amounts of antigen to make 
immunizations. In this experiment the hens were immunized with 0.1-
100 µg of antigen with booster immunizations. Every two weeks for 
eight weeks, the IgY response in the yolk demonstrated a similar picture 
as that in the serum. The study confirmed that it is possible to obtain 
a good immune response with less amounts of antigen than is usually 
recommended to immunize sheep or horses. Studies by some groups have 
established that antibody responses to foreign antigens are genetically 
controlled. It has been feasible to breed hens that are high and low 
antibody responders intramuscularly20 or by intravenous9,16 injections.
Fig. 2 - SDS-PAGE analysis (15% gel concentration, under reducing conditions) of IgY 
Antibodies after precipitation with ammonium sulfate and dialysis. 1) Molecular weight 
markers. 2) IgY. 
Table 2
Effective dose fifty (ED50=477 mg/kg/3 LD50) assay of yielded antibodies (IgY coral snake antivenom neutralizing lethal toxic activity of coral snake venom 
Antivenom concentration 
(mg/mL)
Total protein of 
antivenom (mg/mouse)
Number of mice
Percentage of deaths (%)
Died Lived Total
86 17.2 0 8 8 0
43 8.6 4 4 8 50
21.5 4.3 8 0 8 100
10.7 21.5 8 0 8 100
5.3 5.3 8 0 8 100
ED50 = 477 mg/kga
The ED50 was calculated according to Spearman and Karber 31: 
ED50= the 50% effective dose. log X100 = log dose giving 100% survival and having 100% survival for all higher doses. log Fd = the log dilution factor. N = # mice used 
at each dose level. T = #mice alive at each dose level. Σ = the sum of mice surviving at every dose level. a The ED50 is the effective dose of IgY that will protect 50% 
of the mouse population when injected with 3LD50s.
Fig. 3 - Gel diffusion assay using specific IgY against coral snake venom. 1. Micrurus isozonus 
(Calabozo, Guárico State); 2. PBS; 3. Micrurus isozonus (Caracas, D.C.); 4. Micrurus isozonus 
(La Boyera, Miranda State); 5. PBS; 6. Micrurus isozonus (Maracay, Aragua State); 7. Micrurus 
surinamensis (Amazonas State); 8. PBS; 9. Micrurus dissoleucus dissoleucus (Paraguaná, 
Falcón State); 10. Micrurus tener (Western, USA); 11 PBS; Micrurus fulvius (Eastern, USA).
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The production of IgY from small amounts of antigen required for 
immunization, the ease in collecting the eggs, and the uncomplicated 
purification techniques to enhance the function of immunological assays, 
make the use of IgY attractive and profitable.
Normally, antivenoms are achieved by immunizing horses with 
increasing doses of venom to obtain a high-quality antibody titer8. A range 
of side effects exists in the administration of antivenom; for instance, 
anaphylaxis and serum sickness27. The elevated concentrations of 
proteins, which are not antibodies, existing in many common antivenom 
probably produce most of these symptoms. With the aim of eliminating 
the unpleasant effects of the antivenom treatment, it is necessary to 
achieve antivenom immunoglobulins in a reasonable purification state. 
Investigators24,25,30 have proposed that birds are a suitable and economical 
supply of IgY immunoglobulins. Chicken egg yolks have IgY, which is a 
species-specific immunoglobulin with a molecular weight of 190kDa26. 
Our laboratory has produced hen antibodies against Scolopendra 
gigantea toxins with high titers19. Others have reported the production 
of immunoglobulins against different types of protein antigens, synthetic 
peptides, etc.29. We have improved the production of polyclonal antibodies 
by means of crude coral snake venom injected in hens with an alternative 
protocol, from that of the classical method used for horse immunoglobulin 
production. In our current work, we were capable of obtaining a good 
antibody titer with immunized hens.
Due to the high incidences of coral snake envenomations by M. 
isozonus in Venezuela, this particular snake venom was used to carry out the 
in vivo efficacy test of coral snake IgY antivenom, which resulted in ED50 of 
477 mg/kg body weight (Table 2). This value falls within acceptable ED50 
ranges of other antivenoms tested on different snake venoms7. A Western 
blot was done to determine the specificity of the IgY antivenom to different 
coral snake venoms as well as other Venezuelan venomous species. It 
appears that the IgY coral snake venom antivenom was able to recognize 
all four coral snake venoms used in the immunization protocol with M. 
isozonus, M. surinamensis, M. f. fulvius and M. t. tener having the highest 
recognition. The venom of M. surinamensis was the least reactive (Fig. 
4). In addition to those venoms used to produce the IgY antivenom, two 
cobra venoms (N. kaouthia and N. pallida), and three Venezuelan Viperidae 
species (B. colombiensis, C. d. cumanensis and C. vegrandis) were also 
detected by the antivenom. This cross reactivity suggests there are similar 
venom toxins found in species of snakes located in distinct geographical 
locations. The fact that M. surinamensis had the least reactivity of all 
venoms, including those not used in the immunization protocol, indicates 
the uniqueness of the proteins found in that venom. The possible use of IgY 
in therapy and/or diagnostic assays either in humans or animals provides 
an invaluable field of interesting and useful applications12,17,28.
RESUMEN
Antiveneno de serpiente coral producido en gallinas (Gallus 
domesticus) 
La producción de antiveneno de serpiente usando sangre de grandes 
mamíferos se ha encontrado que es de bajo rendimiento y de trabajo arduo, 
en consecuencia, las inmunoglobulinas antiveneno para el tratamiento se 
obtienen generalmente, como suero polivalente. Hemos estandarizado una 
técnica poco exigente para la fabricación de inmunoglobulina purificada 
IgY, que consistió en generar anticuerpos policlonales contra el veneno de 
la serpiente coral en huevos de gallinas inmunizadas. La técnica consistió 
en la eliminación de lípidos de las yemas del huevo, diluidas en agua y 
en una secuencia de congelación-descongelación. Las inmunoglobulinas 
específicas estuvieron presentes en la yema de huevo hasta 180 días después 
de la inmunización. La unión del antígeno a las inmunoglobulinas se detectó 
mediante un ensayo de inmunodifusión doble. Los títulos de anticuerpos en 
la yema fueron estimados con un ensayo de protección (dosis efectiva media 
= ED50). Dado que las gallinas reproductoras son económicamente viables, 
la recolección de huevos es no invasiva y la purificación de anticuerpos IgY 
es rápida y fácil, la inmunización de la gallina es una excelente alternativa 
para la producción de anticuerpos policlonales. A nuestro entender, esta es 
el primer anti-veneno contra serpiente de coral preparado en aves.
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